Viewing Study NCT05857566


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-01-01 @ 5:00 PM
Study NCT ID: NCT05857566
Status: COMPLETED
Last Update Posted: 2023-11-18
First Post: 2023-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
Sponsor: Response Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module